Evidence map›Paper›PMID 42410545›Full record

ArticleBMC pulmonary medicine2026

A novel percutaneous aspiration sclerotherapy for staged volume reduction of giant single bulla in the treatment of COPD combined with pulmonary bullae.

Wusheng Deng, Chao Li, Yun Jiang, Xiao Hu, Yufei Jiang, Gang Jiang, Yanjun Hu, Cheng Li, Hui Zhang, Jiazhou Yu and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Wusheng Deng *Department of Respiratory and Critical Care Medicine, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 410000, China.
Chao Li *Department of Respiratory and Critical Care Medicine, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 410000, China.
Yun JiangDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Shaoyang University, Shaoyang, China.
Xiao HuDepartment of Respiratory and Critical Care Medicine, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 410000, China.
Yufei JiangFaculty of Healthy Science, University of Macau, Macau, China.
Gang JiangDepartment of Respiratory and Critical Care Medicine, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 410000, China.
Yanjun HuDepartment of Respiratory and Critical Care Medicine, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 410000, China.
Cheng LiDepartment of Respiratory and Critical Care Medicine, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 410000, China.
Hui ZhangDepartment of Respiratory and Critical Care Medicine, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 410000, China.
Jiazhou YuDepartment of Respiratory and Critical Care Medicine, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 410000, China.
Yongliang JiangDepartment of Respiratory and Critical Care Medicine, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 410000, China. yvfei316@163.com.

Funding

National Natural Science Foundation of China (grant number 82070057)
6 · The paper itself

Abstract

backgroundThe efficacy of a novel technique-percutaneous aspiration sclerotherapy for staged volume reduction of giant single bulla-in patients with chronic obstructive pulmonary disease (COPD) combined with pulmonary bullae remains unclear.

methodsA retrospective study was conducted on 40 COPD patients with pulmonary bullae who underwent the novel percutaneous aspiration sclerotherapy for staged volume reduction of giant single bulla technique. Pulmonary bullae size, pulmonary function, blood gas analysis, six-minute walk test (6MWT), modified Medical Research Council (mMRC) score and St. George 's Respiratory Questionnaire (SGRQ) were assessed before and after the procedure. Related complications were also recorded.

resultsThe average size of the giant bullae in the 40 patients was 12.67 ± 2.49 cm. Compared with preoperative data, PaO

conclusionPercutaneous aspiration sclerotherapy for staged volume reduction of giant single bulla is a feasible treatment for pulmonary bullae, involving a straightforward procedure. Nevertheless, its long-term clinical efficacy remains to be further validated in follow-up studies.

Indexed as

BlisterPulmonary Disease, Chronic ObstructiveSclerotherapyAgedFemaleForced Expiratory VolumeHumansMaleMiddle AgedRespiratory Function TestsRetrospective StudiesTreatment OutcomeVital CapacityWalk TestCOPDPercutaneousPulmonary bullaVolume reduction

Identifiers

PMID42410545
PMCPMC13621723

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.